SirolimusImmunosuppressive AgentsTacrolimusCyclosporineMycophenolic AcidKidney TransplantationImmunosuppressionGraft RejectionCalcineurinAzathioprineGraft SurvivalImmune ToleranceTransplantation, HomologousAntilymphocyte SerumDrug Therapy, CombinationCyclosporinsLiver TransplantationTreatment OutcomePolyenesDrug SubstitutionT-LymphocytesHeart TransplantationTransplantationPrednisoloneTime FactorsIslets of Langerhans TransplantationLymphangioleiomyomatosisTOR Serine-Threonine KinasesAngiomyolipomaLymphocyte ActivationOrgan TransplantationKidneyAdrenal Cortex HormonesDrug MonitoringAnemia, AplasticRetrospective StudiesImmunocompromised HostLymphangiomyomaT-Lymphocytes, RegulatoryCreatinineFollow-Up StudiesMethylprednisolonePrednisoneInjections, IntraocularMice, Inbred BALB CGlucocorticoidsCoronary RestenosisAntibodies, MonoclonalInterleukin-10SteroidsGraft vs Host DiseaseCells, CulturedBiopsyAmino Acid IsomerasesIndoleamine-Pyrrole 2,3,-DioxygenaseChyleMice, Inbred C57BLDose-Response Relationship, DrugAnti-Inflammatory AgentsTransplantation ImmunologyGlomerular Filtration RateSkin TransplantationCell ProliferationLymphocytesPostoperative ComplicationsSpleenCyclophosphamideDrug-Eluting StentsCytokinesTissue DonorsInterleukin-2Antibiotics, AntineoplasticLymphocyte Culture Test, MixedRecurrenceLiving DonorsPropylene GlycolsDrug InteractionsOpportunistic InfectionsProspective StudiesCardiovascular AgentsTransplantation ConditioningTransplantation ToleranceKidney Function TestsAutoimmune DiseasesDendritic CellsProteinuriaFlow CytometryInfectionTumor EscapeDrug ImplantsPancreas TransplantationFluorescence Polarization ImmunoassayMethotrexateAntibody FormationStentsKidney DiseasesThrombotic MicroangiopathiesTubulin ModulatorsMyeloid CellsPeptidylprolyl Isomerase